vorinostat has been researched along with Intestinal Perforation in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Intestinal Perforation: Opening or penetration through the wall of the INTESTINES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rettenmaier, MA | 1 |
| Wong, H | 1 |
| Stone, MK | 1 |
| Bechtol, K | 1 |
| Goldstein, BH | 1 |
1 other study available for vorinostat and Intestinal Perforation
| Article | Year |
|---|---|
Vorinostat is a potential precipitant for severe gastrointestinal toxicity.
Topics: Antineoplastic Agents; Enterostomy; Female; Humans; Hydroxamic Acids; Intestinal Perforation; Middle | 2013 |